According to the World Health Organization (WHO), an estimated 17.9 million people die annually due to cardiovascular disease. As February is American Heart Health Month, focusing on raising awareness for the leading global cause of death, NAMSA experts have identified key pivotal topics every cardiovascular MedTech developer should consider. These insights can often be the difference between a successful product launch, a failed launch or a costly delay for many developers.
NAMSA invites you to join us for this webinar, featuring a panel of recognized leaders in cardiovascular product development, as we discuss the latest industry trends and best practices related to cardiovascular MedTech development.
Attendees can expect to walk away with the following insights:
- Considerations for developing novel technologies vs. iterating an existing technology
- Managing new trends – Are they a distraction or a valuable tool?
- Balancing planning, execution and flexibility in your product development plan
- Surviving when disaster strikes – How to navigate a successful outcome